Orgalutran 0.25mg Injection
By Orgalutran
Rx
1ml Injection in a Vial

Composition
Ganirelix(0.25mg)

Manufacturer - Organon (India) Ltd
Gala No-1C, Bldg No. -B3, City Link Warehouse Com, Mumbai Nashik Highway,Vadapa, Tal Bhiwandi, Distt Thane 421 302

Expires on or after
April, 2026

liver
If you have liver disease, you should be cautious when using Orgalutran 0.25mg Injection. Your doctor may need to adjust the dose for you. It is not recommended to use Orgalutran 0.25mg Injection if you have moderate to severe liver disease. Always consult your doctor before using this medication.

kidney
Orgalutran 0.25mg Injection needs caution in kidney disease patients. Dose adjustments may be necessary, consult your doctor before use. Avoid in moderate to severe kidney disease.

alcohol
Caution is advised when consuming alcohol with Orgalutran 0.25mg Injection. It is important to consult your doctor.

driving
It is not clear if Orgalutran 0.25mg Injection affects driving ability. Avoid driving if you have symptoms impacting focus and reaction time.

pregnancy
Orgalutran 0.25mg Injection is not safe during pregnancy, as studies on pregnant women and animals have shown harm to the developing baby. Seek advice from your doctor regarding its use.

breastfeeding
Orgalutran 0.25mg Injection is not recommended for use while breastfeeding because it may pose a risk of toxicity to the baby.
Habit Forming | No |
Chemical Class | Polypeptides |
Therapeutic Class | - |
Action Class | GNRH antagonists |
₹2382
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024